Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.76
-0.55 (-2.17%)
At close: Nov 3, 2025, 4:00 PM EST
25.24
+0.48 (1.94%)
After-hours: Nov 3, 2025, 5:18 PM EST

Arcutis Biotherapeutics Revenue

Arcutis Biotherapeutics had revenue of $99.22M in the quarter ending September 30, 2025, with 121.69% growth. This brings the company's revenue in the last twelve months to $317.93M, up 129.21% year-over-year. In the year 2024, Arcutis Biotherapeutics had annual revenue of $196.54M with 229.74% growth.

Revenue (ttm)
$317.93M
Revenue Growth
+129.21%
P/S Ratio
10.06
Revenue / Employee
$929,617
Employees
342
Market Cap
3.03B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024196.54M136.94M229.74%
Dec 31, 202359.61M55.92M1,517.09%
Dec 31, 20223.69M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca56.50B
Novartis AG56.37B
Novo Nordisk49.11B
Revenue Rankings